Komodo Health Secures $50 Million Series C Funding to Expand Its Healthcare Map Platform

VCBeat (WeChat ID: vcbeat) learned from foreign media that on January 8, 2020, healthcare intelligence platform Komodo Health completed a $50 million Series C financing round. The round was led by Andreessen Horowitz, with participation from Oak HC/FT, IA Ventures, and Felicis Ventures.

Komodo Health is a leading modern healthcare intelligence platform dedicated to leveraging real-time data to improve healthcare decision-making. The Komodo Health Healthcare Map provides customers and partners with the essential software support needed to address the most complex challenges in healthcare. Currently, Komodo Health connects thousands of healthcare data sources to reveal the truth about patient journeys through the U.S. healthcare system. By applying AI to the Healthcare Map, Komodo Health generates predictive and prescriptive insights, thereby applying advanced analytics to tackle the biggest challenges in healthcare. Komodo Health’s products deploy the Healthcare Map and AI-driven insights to identify the most effective pathways for reducing disease burden.

It is reported that since its establishment in 2014, Komodo Health has raised over $70 million in funding. This financing will be used to develop new software for life sciences companies, healthcare consumers and providers, and patient advocacy groups, as well as to expand its Healthcare Map and end-to-end analytics platform.

Arif Nathoo, M.D., CEO and Co-Founder of Komodo Health, stated, “Our platform is designed to leverage healthcare experience to deliver optimal medical outcomes for patients. By leveraging extensive knowledge and technology-driven insights, Komodo Health identifies disparities in healthcare delivery, determines appropriate interventions, and ultimately makes a significant impact on patient care.”

Web Sun, President and Co-Founder of Komodo Health, stated, “Despite the ongoing digitalization of healthcare services, challenges posed by fragmented information and limited interoperability of medical data are hindering the achievement of better patient outcomes. As the company grows, Komodo’s unique platform will drive innovation across the entire healthcare ecosystem to reduce the burden of disease.”

Jorge Conde, a partner at Andreessen Horowitz, stated: “Komodo Health has built a living map of the U.S. healthcare system, which will enable all healthcare stakeholders to navigate our system.”

Andreessen Horowitz, founded in 2009, is a venture capital firm based in Silicon Valley, California, dedicated to supporting bold entrepreneurs in building the future through technology. Andreessen Horowitz provides entrepreneurs with expertise and insights spanning the entire company-building process, aiming to connect entrepreneurs, investors, executives, engineers, scholars, industry experts, and other participants in the technology ecosystem.

Oak HC/FT is a venture capital fund investing in healthcare information and services (“HC”) and financial services technology (“FT”). Oak HC/FT is uniquely positioned to deliver returns to investors and foster innovative businesses by providing strategic advisory services to entrepreneurs and companies. Over the past decade, Oak HC/FT’s partners have completed 20 transactions, with six portfolio companies achieving valuations exceeding $1 billion. Led by Oak Investment Partners’ healthcare and fintech teams, Oak HC/FT is part of Oak’s strategy to develop sector-specific funds and continue its tradition of building best-in-class businesses.

IA Ventures is an early-stage venture capital firm headquartered in New York. IA Ventures tends to provide seed funding to companies before they generate one dollar in revenue.

Felicis Ventures is a venture capital firm based in Menlo Park. Felicis invests in iconic companies that are reshaping core markets, as well as cutting-edge technology companies.

(Compiled by: Chang Jia)